News & Blog

Tag Archives: GBM

Immunotherapy Q&A with Dr. John Sampson (Part II)

Below is Part II of our two-part Q&A with Dr. John Sampson of Duke University on the topic of immunotherapy. In Part I of this Q&A last week, Dr. Sampson discussed what immunotherapy means and how it works, what the different types of immunotherapy are, how they differ from other treatment types, and where they […]

Defeat GBM Research Collaborative Produces Important Discovery

As we wrote on this blog back in May, the issue of “acquired resistance” is one of the biggest challenges in successfully treating brain tumors. Acquired resistance refers to tumor cells’ ability to learn to dodge the effects of treatment. Once a tumor develops resistance, current drugs stop working and the tumor can resume growing. […]

Five Key Updates from the 2014 Scientific Meeting of the Society for Neuro-Oncology

The Society for Neuro-Oncology (SNO) Annual Scientific Meeting is a multi-day conference that serves as one of the most important gatherings in the field of brain tumor research and drug development. Over three days, presentations are given on some of the most promising research efforts in the field, as well as critical updates on many […]

Share